Fust Matthew K

Insider·Crinetics Pharmaceuticals, Inc.·CRNX·Insider since 2025·Form 4 filings: 1
Trades YTD
0
Trades (12m)
1
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

1 transactions
26 Sep 2025
SOLD
$CRNX
16,000
$44.75
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Crinetics Pharmaceuticals, Inc.

last 30 days

No active insider cluster at Crinetics Pharmaceuticals, Inc. in the last 30 days. K's recent transactions appear in the section above.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 14:47 UTC.